Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
187.46B | 191.08B | 191.25B | 174.17B | 153.73B | Gross Profit |
46.54B | 42.35B | 40.21B | 41.87B | 38.25B | EBIT |
17.19B | 14.32B | 13.44B | 15.76B | 13.71B | EBITDA |
18.59B | 14.94B | 14.49B | 16.36B | 12.95B | Net Income Common Stockholders |
12.20B | 9.60B | 9.28B | 10.01B | 7.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
48.52B | 41.14B | 24.57B | 31.81B | 23.96B | Total Assets |
120.73B | 102.19B | 95.22B | 87.36B | 77.25B | Total Debt |
14.97B | 10.09B | 12.71B | 9.29B | 10.93B | Net Debt |
-33.55B | -31.05B | -11.85B | -22.52B | -13.03B | Total Liabilities |
41.38B | 33.90B | 35.94B | 35.03B | 33.05B | Stockholders Equity |
79.18B | 67.22B | 58.37B | 51.52B | 43.32B |
Cash Flow | Free Cash Flow | |||
5.04B | 21.33B | -7.99B | 11.29B | 8.77B | Operating Cash Flow |
8.20B | 24.02B | -6.76B | 13.17B | 10.58B | Investing Cash Flow |
-6.20B | -2.74B | -1.19B | -1.52B | -2.02B | Financing Cash Flow |
-132.00M | -5.81B | 224.00M | -4.07B | -5.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $22.80T | 19.98 | 14.40% | 0.52% | 9.56% | 26.52% | |
77 Outperform | ¥16.77T | 27.44 | 10.50% | 1.06% | 0.56% | 5.32% | |
73 Outperform | ¥3.49T | 23.65 | 2.54% | 0.23% | 12.16% | ||
73 Outperform | $5.80T | 26.08 | 11.70% | 0.85% | -5.48% | -11.96% | |
71 Outperform | ¥130.26B | 9.91 | 3.01% | 8.73% | 10.23% | ||
69 Neutral | $14.39T | 45.00 | 12.13% | 0.88% | -27.51% | -35.35% | |
60 Neutral | $10.93B | 10.46 | -6.70% | 2.99% | 7.54% | -12.22% |